stockrow
Friday 6 November 2026
Export SGRY’s income statement to Excel — free account
Surgery Partners, Inc.
SGRY Healthcare Medical Care Facilities
Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024.
- Revenue
- +2.75%
- EPS
- −500.0%
- Free cash flow
- −60.6%
- Total debt
- +4.92%
Quarter to June 2026, against a year earlier
23.20
0.03
+0.13%
Follow SGRY
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
81.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
6 | 3 | 4 | 3 | 3 | 7 | 7 | 6 | 5 | 4 |
P/S ratio |
0.65 | 0.48 | 0.27 | 0.41 | 0.76 | 1.74 | 0.95 | 1.45 | 0.86 | 0.59 |
Altman Z-Score |
0.92 | 0.58 | 0.52 | 0.59 | 0.61 | 1.06 | 0.93 | 1.14 | 0.83 | 0.75 |
Altman Z″-Score (non-manufacturers) |
0.82 | 1.17 | 0.76 | 0.69 | 0.61 | 1.01 | 1.33 | 1.25 | 1.14 | 1.11 |
P/FCF ratio |
8.64 | 7.07 | 3.79 | 10.29 | 5.39 | 108.97 | 26.55 | 17.21 | 12.58 | 8.12 |
Beneish M-Score |
(2.31) | (2.10) | (2.61) | (2.49) | (2.45) | (2.39) | (2.47) | (2.55) | (2.55) | (2.52) |
P/Operating CF |
22.99 | 11.86 | 10.33 | 29.77 | 158.99 | 196.36 | 335.88 | 63.47 | 23.97 | 19.01 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 4 |
P/B ratio |
2.29 | 0.48 | 0.43 | 0.77 | 1.60 | 1.96 | 0.82 | 1.31 | 0.84 | 0.63 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.85 | 1.98 | 1.47 | 1.77 | 2.13 | 2.88 | 1.87 | 2.39 | 1.85 | 1.64 |
EV/EBITDA |
8.79 | 12.28 | 16.95 | 10.06 | 13.70 | 15.56 | 10.07 | 14.23 | 11.08 | 9.22 |
EV/Operating CF |
16.90 | 22.00 | 18.07 | 25.05 | 16.01 | 73.68 | 29.96 | 22.30 | 19.23 | 19.79 |
EV/FCF |
24.58 | 29.13 | 21.07 | 44.14 | 15.06 | 180.77 | 52.22 | 28.39 | 27.18 | 22.42 |
Quick Ratio |
1.55 | 1.53 | 1.41 | 1.05 | 1.26 | 1.53 | 1.50 | 1.32 | 1.36 | 1.37 |
Current Ratio |
1.94 | 1.86 | 1.68 | 1.32 | 1.44 | 1.76 | 1.87 | 1.71 | 1.79 | 1.87 |
Net Debt/EBITDA |
5.70 | 9.30 | 13.90 | 7.71 | 8.80 | 6.18 | 4.95 | 5.60 | 5.95 | 5.88 |
Debt/Assets |
62.57% | 47.36% | 49.75% | 51.42% | 52.77% | 48.04% | 39.24% | 40.36% | 42.72% | 45.60% |
Debt/Equity |
4.44 | 1.31 | 1.60 | 1.87 | 2.17 | 1.49 | 0.89 | 0.91 | 1.05 | 1.18 |
Asset Turnover |
0.52 | 0.39 | 0.38 | 0.38 | 0.36 | 0.39 | 0.40 | 0.40 | 0.42 | 0.41 |
Operating CF/Net income |
13.25 | (1.53) | (0.61) | (1.17) | (1.59) | (1.07) | (2.91) | (24.69) | (1.79) | (3.52) |
Capex/Depreciation |
(0.99) | (0.57) | (0.31) | (0.73) | 0.16 | (0.52) | (0.59) | (0.53) | (0.58) | (0.18) |
Interest Coverage |
2.00 | 1.40 | 0.59 | 1.38 | 0.96 | 1.42 | 1.52 | 1.77 | 1.83 | 1.51 |
| 3.04% | (9.52%) | (19.55%) | (10.61%) | (16.68%) | (5.69%) | (2.22%) | (0.40%) | (5.40%) | (2.46%) | |
| 0.43% | (2.28%) | (5.12%) | (2.28%) | (2.98%) | (1.41%) | (0.85%) | (0.18%) | (2.28%) | (0.97%) | |
ROIC |
7.24% | 2.69% | 1.35% | 3.81% | 2.97% | 4.18% | 4.09% | 3.65% | 3.46% | 3.69% |
Return on Tangible Assets |
2.49% | (12.01%) | (35.79%) | (16.98%) | (19.71%) | (7.82%) | (4.19%) | (0.89%) | (10.62%) | (4.61%) |
Average Days of Receivables |
70.29 | 78.38 | 63.38 | 65.15 | 75.00 | 70.57 | 65.59 | 66.05 | 67.87 | 66.43 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
5.26% | 5.67% | 5.28% | 4.84% | 2.74% | 2.97% | 4.02% | 4.41% | 4.45% | 3.57% |
Intangible Assets out of Total Assets |
0.70 | 0.74 | 0.74 | 0.69 | 0.65 | 0.65 | 0.63 | 0.64 | 0.65 | 0.64 |
Share Based Compensation of Revenue |
0.18% | 0.42% | 0.52% | 0.56% | 0.71% | 0.78% | 0.72% | 0.65% | 1.07% | 0.45% |
Graham Net Nets |
(2.17) | (3.71) | (5.59) | (4.12) | (2.33) | (0.83) | (1.17) | (0.74) | (1.34) | (1.95) |
Graham Number |
5.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
1.23% | (12.28%) | (50.66%) | (14.50%) | (10.96%) | (2.32%) | (2.21%) | (0.32%) | (6.28%) | (4.01%) |
Free Cash Flow Yield |
11.57% | 14.15% | 26.37% | 9.72% | 18.55% | 0.92% | 3.77% | 5.81% | 7.95% | 12.32% |
Revenue per Share |
23.85 | 27.76 | 36.88 | 37.93 | 38.14 | 30.72 | 27.62 | 21.84 | 24.69 | 26.01 |
Operating CF per Share |
2.61 | 2.50 | 3.01 | 2.68 | 5.06 | 1.20 | 1.73 | 2.34 | 2.38 | 2.16 |
Capex per Share |
(0.81) | (0.61) | (0.43) | (1.16) | 0.32 | (0.71) | (0.74) | (0.50) | (0.70) | (0.25) |
Free Cash Flow per Share |
1.79 | 1.89 | 2.58 | 1.52 | 5.38 | 0.49 | 0.99 | 1.84 | 1.68 | 1.90 |
Cash per Share |
1.45 | 3.62 | 3.84 | 1.92 | 6.52 | 5.38 | 3.08 | 1.56 | 2.14 | 1.89 |
Shareholders Equity per Share |
6.76 | 34.51 | 30.36 | 28.55 | 26.99 | 27.19 | 31.98 | 24.16 | 25.34 | 24.62 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.76 | 34.51 | 30.36 | 28.55 | 26.99 | 27.19 | 31.98 | 24.16 | 25.34 | 24.62 |
Free Cash Flow |
86.13 | 91.30 | 124.00 | 73.50 | 262.50 | 35.50 | 91.10 | 230.80 | 212.30 | 242.10 |
Working Capital |
175.23 | 260.22 | 239.00 | 127.40 | 244.70 | 409.30 | 427.60 | 372.00 | 495.00 | 535.20 |
Capital Expenditures |
(39.11) | (29.60) | (20.60) | (56.00) | 15.60 | (51.60) | (67.70) | (63.00) | (87.80) | (32.20) |
Net Current Asset Value |
(1,618.33) | (2,392.13) | (2,629.80) | (3,115.00) | (3,295.10) | (3,201.90) | (2,820.20) | (2,947.20) | (3,574.20) | (3,837.70) |
EV/EBIT |
10.52 | 16.15 | 30.13 | 13.18 | 20.40 | 20.47 | 13.30 | 19.15 | 15.67 | 13.16 |
Capex to Sales |
0.03 | 0.02 | 0.01 | 0.03 | (0.01) | 0.02 | 0.03 | 0.02 | 0.03 | 0.01 |
Price to Operating Income |
3.79 | 4.07 | 6.04 | 3.21 | 7.73 | 12.80 | 7.01 | 12.11 | 7.65 | 5.05 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.19 | 0.13 | 0.16 | 0.15 | 0.17 | 0.16 | 0.13 | 0.12 | 0.14 | 0.15 |
Cash ROIC |
4.69% | 2.26% | 3.12% | 1.81% | 5.84% | 0.67% | 1.56% | 3.84% | 3.11% | 3.42% |
Accounts Receivable Turnover |
5.74 | 5.27 | 5.95 | 5.77 | 5.25 | 5.48 | 5.73 | 5.76 | 5.79 | 5.60 |
Accounts Payable Turnover |
17.27 | 15.08 | 16.21 | 15.64 | 15.04 | 15.40 | 14.21 | 12.96 | 12.45 | 12.19 |
Inventory Turnover |
30.21 | 27.50 | 30.82 | 31.38 | 28.83 | 29.51 | 29.65 | 28.59 | 28.96 | 27.50 |
Average Days of Payables |
22.12 | 30.50 | 22.33 | 25.08 | 24.71 | 26.30 | 28.17 | 29.92 | 32.16 | 29.95 |
Days of Inventory on Hand |
12.79 | 16.18 | 11.64 | 12.01 | 13.91 | 12.86 | 13.27 | 13.10 | 13.62 | 13.86 |
Average Receivables |
199.71 | 254.31 | 297.81 | 317.25 | 354.55 | 406.20 | 443.25 | 476.35 | 537.75 | 590.65 |
Average Payables |
47.55 | 67.24 | 84.01 | 90.00 | 98.45 | 112.55 | 138.25 | 161.70 | 190.25 | 208.70 |
Average Inventory |
27.18 | 36.86 | 44.18 | 44.85 | 51.35 | 58.75 | 66.25 | 73.30 | 81.80 | 92.50 |
Average Assets |
2,204.70 | 3,463.87 | 4,649.54 | 4,847.60 | 5,216.05 | 5,765.40 | 6,399.85 | 6,779.40 | 7,383.35 | 8,004.85 |
Average Common Equity |
311.30 | 830.64 | 1,217.76 | 1,041.15 | 932.75 | 1,425.85 | 2,455.25 | 2,987.70 | 3,115.45 | 3,163.85 |
Columns are period end dates